Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	68061
Country	Switzerland

Received	2021-05-10 17:44
Peer-Review Started	2021-05-10 17:47
To Make the First Decision
Return for Revision	2021-06-16 01:31
Revised	2021-08-02 20:01
Second Decision	2021-12-27 03:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-12-28 07:40
Articles in Press	2021-12-28 07:40
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-12-22 07:11
Typeset the Manuscript	2022-01-25 17:03
Publish the Manuscript Online	2022-02-10 14:26

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Minireviews
Article Title	Multimodal treatment in oligometastatic gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Mickael Chevallay, Charles-Henri Wassmer, Pouya Iranmanesh, Minoa K Jung and Stefan P Mönig
ORCID	Author(s) ORCID Number Mickael Chevallay http://orcid.org/0000-0002-0056-2674 Charles-Henri Wassmer http://orcid.org/0000-0002-9018-7088 Pouya Iranmanesh http://orcid.org/0000-0002-6963-1164 Minoa K Jung http://orcid.org/0000-0003-2352-4774 Stefan P Mönig http://orcid.org/0000-0002-1256-7755
Funding Agency and Grant Number
Corresponding Author	Stefan P Mönig, MD, Surgeon, Division of Visceral Surgery, Department of Surgery, University of Geneva Hospitals, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland. stefan.moenig@hcuge.ch
Key Words	Gastric cancer; Radiotherapy; Chemotherapy; Multimodal treatment; Oligometastatis; Immunotherapy
Core Tip	Oligometastatic gastric cancer is an increasingly recognized clinical entity characterized by limited metastatic spread. With the development of multimodal treatment, curative treatment with complete surgical resection can be achieved. In our review, we have shown evidence that chemotherapy, immunotherapy, and targeted therapy could control the expansion of the tumor or decrease the size of the metastasis to achieve a resectable configuration. Surgery is not only a palliative option for metastatic disease but could be offered with curative intent in selected patients.
Publish Date	2022-02-10 14:26
Citation	Chevallay M, Wassmer CH, Iranmanesh P, Jung MK, Mönig SP. Multimodal treatment in oligometastatic gastric cancer. World J Gastrointest Oncol 2022; 14(2): 434-449
URL	https://www.wjgnet.com/1948-5204/full/v14/i2/434.htm
DOI	https://dx.doi.org/10.4251/wjgo.v14.i2.434

Full Article (PDF)	WJGO-14-434.pdf
Full Article (Word)	WJGO-14-434.docx
Manuscript File	68061_Auto_Edited-LLW-Filipodia.docx
Answering Reviewers	68061-Answering reviewers.pdf
Audio Core Tip	68061-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	68061-Conflict-of-interest statement.pdf
Copyright License Agreement	68061-Copyright license agreement.PDF
Non-Native Speakers of English Editing Certificate	68061-Language certificate.pdf
Peer-review Report	68061-Peer-review(s).pdf
Scientific Misconduct Check	68061-Bing-Wang LL-2.png
Scientific Editor Work List	68061-Scientific editor work list.pdf